9.84
price up icon0.31%   0.03
after-market After Hours: 10.20 0.36 +3.66%
loading
89 Bio Inc stock is traded at $9.84, with a volume of 2.37M. It is up +0.31% in the last 24 hours and up +30.33% over the past month. 89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$9.81
Open:
$9.66
24h Volume:
2.37M
Relative Volume:
1.21
Market Cap:
$1.44B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-4.9949
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
+3.69%
1M Performance:
+30.33%
6M Performance:
+9.45%
1Y Performance:
+26.48%
1-Day Range:
Value
$9.3701
$10.30
1-Week Range:
Value
$8.94
$10.30
52-Week Range:
Value
$4.16
$11.84

89 Bio Inc Stock (ETNB) Company Profile

Name
Name
89 Bio Inc
Name
Phone
(415) 432-9270
Name
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Name
Employee
93
Name
Twitter
Name
Next Earnings Date
2024-12-07
Name
Latest SEC Filings
Name
ETNB's Discussions on Twitter

Compare ETNB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ETNB
89 Bio Inc
9.84 1.39B 0 -174.61M -165.54M -1.97
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

89 Bio Inc Stock (ETNB) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-14-25 Initiated Goldman Neutral
Mar-13-25 Initiated Citigroup Buy
Feb-04-25 Initiated Wolfe Research Outperform
Apr-22-24 Resumed BofA Securities Buy
Jan-12-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Oct-10-23 Downgrade Oppenheimer Outperform → Perform
Aug-28-23 Initiated UBS Buy
Jun-13-23 Initiated Evercore ISI Outperform
May-12-22 Upgrade Raymond James Outperform → Strong Buy
Dec-20-21 Initiated H.C. Wainwright Buy
Oct-26-21 Resumed Cantor Fitzgerald Overweight
Jul-29-21 Resumed BTIG Research Buy
May-25-21 Downgrade Raymond James Strong Buy → Outperform
Apr-21-21 Initiated Cantor Fitzgerald Overweight
Oct-19-20 Initiated Raymond James Strong Buy
Sep-25-20 Upgrade BofA Securities Neutral → Buy
Jul-31-20 Initiated Piper Sandler Overweight
Jul-23-20 Initiated BTIG Research Buy
Jul-07-20 Initiated Chardan Capital Markets Buy
Dec-09-19 Initiated BofA/Merrill Neutral
Dec-09-19 Initiated Oppenheimer Outperform
Dec-09-19 Initiated RBC Capital Mkts Outperform
Dec-09-19 Initiated SVB Leerink Outperform
View All

89 Bio Inc Stock (ETNB) Latest News

pulisher
May 31, 2025

89bio, Inc. (NASDAQ:ETNB) Holdings Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 31, 2025
pulisher
May 31, 2025

89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 31, 2025
pulisher
May 30, 2025

89bio Elects Directors and Approves Proposals at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

89bio holds annual meeting, directors elected - Investing.com

May 30, 2025
pulisher
May 30, 2025

89bio Inc (NASDAQ: ETNB) Is A Blank Check For Growth - Stocksregister

May 30, 2025
pulisher
May 29, 2025

Deutsche Bank AG Has $610,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 29, 2025
pulisher
May 28, 2025

Millennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 28, 2025
pulisher
May 27, 2025

89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating Maintained | ETNB Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

89bio price target lowered to $30 from $31 at BofA - TipRanks

May 27, 2025
pulisher
May 27, 2025

89bio’s (ETNB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World

May 27, 2025
pulisher
May 22, 2025

Is 89bio (NASDAQ:ETNB) A Risky Investment? - simplywall.st

May 22, 2025
pulisher
May 20, 2025

Northern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 20, 2025
pulisher
May 16, 2025

BNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB) - The AM Reporter

May 16, 2025
pulisher
May 15, 2025

Will Other Major MASH Deals Follow GSK/Boston Pharma? - insights.citeline.com

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 15, 2025
pulisher
May 15, 2025

89bio, Inc. (NASDAQ:ETNB) Stock Holdings Increased by Price T Rowe Associates Inc. MD - Defense World

May 15, 2025
pulisher
May 14, 2025

Voya Investment Management LLC Sells 1,476 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Invests $87,000 in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 13, 2025
pulisher
May 11, 2025

Weiss Ratings Reaffirms “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World

May 11, 2025
pulisher
May 10, 2025

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News - GuruFocus

May 10, 2025
pulisher
May 10, 2025

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 10, 2025
pulisher
May 09, 2025

89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts - Defense World

May 09, 2025
pulisher
May 07, 2025

Deeper Dive: Understanding 89bio Inc (ETNB) Through its Various Ratios - DWinneX

May 07, 2025
pulisher
May 07, 2025

MetLife Investment Management LLC Raises Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 07, 2025
pulisher
May 06, 2025

89bio to Participate in Upcoming Investor Conferences - The Manila Times

May 06, 2025
pulisher
May 06, 2025

89bio Schedules Double Fireside Chats: Key Updates Coming at Major Healthcare Conferences - Stock Titan

May 06, 2025
pulisher
May 06, 2025

89bio Inc. Reports Q1 2025 Financial Results - TipRanks

May 06, 2025
pulisher
May 05, 2025

Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 05, 2025
pulisher
May 05, 2025

Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World

May 05, 2025
pulisher
May 03, 2025

Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World

May 03, 2025
pulisher
May 03, 2025

Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus

May 03, 2025
pulisher
May 02, 2025

89bio, Inc. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

89bio Inc [NASDAQ: ETNB] Sees Increase in Stock Value - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight By Investing.com - Investing.com Nigeria

May 02, 2025
pulisher
May 02, 2025

Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight - Investing.com

May 02, 2025
pulisher
May 02, 2025

89bio (ETNB) Poised for Success with Advancements in MASH Trials - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to “Strong-Buy” - Defense World

May 02, 2025
pulisher
May 01, 2025

89bio Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times

May 01, 2025
pulisher
May 01, 2025

There is no doubt that 89bio Inc (ETNB) ticks all the boxes. - Sete News

May 01, 2025
pulisher
Apr 30, 2025

Insider’s View: Deciphering 89bio Inc (ETNB)’s Financial Health Through Ratios - DWinneX

Apr 30, 2025
pulisher
Apr 29, 2025

Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Legal & General Group Plc Sells 4,860 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Apr 29, 2025
pulisher
Apr 26, 2025

89bio, Inc. (NASDAQ:ETNB) Holdings Trimmed by Russell Investments Group Ltd. - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

89bio’s (ETNB) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

89bio Inc [ETNB] stock for 91,208 USD was sold by Le-Nguyen Quoc - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co. - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Market Watch: 89bio Inc (ETNB)’s Noteworthy Gain, Closing at 6.55 - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

A look into 89bio Inc (ETNB)’s deeper side - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

89bio Sees Unusually Large Options Volume (NASDAQ:ETNB) - Defense World

Apr 23, 2025

89 Bio Inc Stock (ETNB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Cap:     |  Volume (24h):